William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Explainer-What is at stake for investors in Kenya's elections?
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497 WILLIAM BLAIR FUNDS
-
CLEARLAKE CAPITAL COMPLETES SALE OF BRIGHTLY SOFTWARE TO SIEMENS
-
Poseida Therapeutics (PSTX) Prices 20M Share Offering at $3.50/sh
-
Poseida Therapeutics Announces Pricing of Public Offering of Common Stock
-
Poseida Therapeutics (PSTX) Announces Proposed Stock Offering, Size not Disclosed
-
RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO
-
RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO
-
Poseida Therapeutics Announces Proposed Public Offering of Common Stock
-
Poseida Therapeutics (PSTX) Announces Proposed Stock Offering, Size not Disclosed
-
Poseida Therapeutics Announces Proposed Public Offering of Common Stock
-
Sarepta's (SRPT) "Products Offer Significant Upside" - William Blair Reiterates Stock at Outperform
-
EverQuote to Participate in Upcoming Investor Conferences
-
EverQuote to Participate in Upcoming Investor Conferences
-
Greenhill & Co. Reports Second Quarter 2022 Results
-
Banner Ventures Further Expands Investment Team as Demand for Partnership Capital Grows
-
Kin Insurance Surpasses $70 Million in Gross Written Premium in Second Quarter, Increasing 204% Year-to-Date
-
Gryphon Investors Completes Majority Investment in Rootstock Software, a Leading Provider of Enterprise Resource Planning ("ERP") Software, to Accelerate Growth in Large Global ERP Market
-
William Blair Investment Management Introduces Emerging Markets ex China Growth Fund
-
OpenGov Continues Expansion with Acquisition of Operations and Asset Management Leader Cartegraph to Address the Growing Demand for Infrastructure Improvements
-
William Blair Reiterates Outperform Rating on Seagen (SGEN) Following Results from cohort K of the Phase Ib/II EV-103, Offers Comments
-
KKR Completes Majority Investment in apexanalytix Alongside Carousel Capital
-
Verve Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
-
Verve Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
-
NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation (FLAC) Announce Merger Agreement
-
NewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Transformative Oral Therapies for Major Cardiom
-
UPDATE: William Blair Starts SS&C Technologies Holdings, Inc. (SSNC) at Outperform
-
UPDATE: William Blair Starts SEI Investments (SEIC) at Market Perform
-
UPDATE: William Blair Starts AssetMark Financial Holdings Inc. (AMK) at Outperform
-
UPDATE: William Blair Starts Envestnet (ENV) at Outperform
-
VistaGen (VTGN) Downgraded at William Blair on PALISADE-1 Failure, "Uncertainty on Path Forward for PH94B"
-
William Blair Expands Tech-Enabled Services Coverage With Three Senior Investment Banking Hires
-
Leading Atlassian Partner Valiantys Secures Investment from Tercera to Expand Its Global Reach
-
Verve Therapeutics (VERV) Prices Upsized 8.33M Share Offering at $27/sh
-
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
-
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
-
Verve Therapeutics (VERV) Announces Proposed $200M Share Offering
-
Verve Therapeutics Announces Proposed Public Offering of Common Stock
-
Verve Therapeutics Announces Proposed Public Offering of Common Stock
-
Form D/A William Blair: Non-US
-
StepStone Group (STEP) and RedBird Capital Acquire Talent Systems
-
RedBird Capital Partners to Acquire Talent Systems, The Industry’s Premier Tech-Driven Global Casting Marketplace
-
Trinity Life Sciences Acquires D Cube Analytics
-
Fidelity Payment Services Announces Strategic Growth Investment from PSG
-
El Car Wash Announces Acquisition by Warburg Pincus
-
UPDATE: William Blair Downgrades 10X Genomics (TXG) to Market Perform
-
IMF hopes to soon resume Sri Lanka high-level discussions
-
Concord Health Partners Expands Senior Team, Adds Healthcare Investment Veterans Erik Larsen and Derek Schmidt
-
William Blair Reiterates Outperform Rating on Xenon Pharmaceuticals (XENE)

